Microbot Medical Inc.
MBOT
$2.61
$0.187.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 151.37% | 13.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.94% | 31.42% | |||
| Operating Income | -3.94% | -31.42% | |||
| Income Before Tax | -5.51% | -30.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.51% | -30.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.51% | -30.43% | |||
| EBIT | -3.94% | -31.42% | |||
| EBITDA | -3.88% | -31.24% | |||
| EPS Basic | -1.08% | -17.59% | |||
| Normalized Basic EPS | -1.07% | -17.53% | |||
| EPS Diluted | -1.08% | -17.59% | |||
| Normalized Diluted EPS | -1.07% | -17.53% | |||
| Average Basic Shares Outstanding | 4.36% | 10.94% | |||
| Average Diluted Shares Outstanding | 4.36% | 10.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||